Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination

Journal of Experimental Medicine

Volumn 193, Issue 4, 2001, Pages 427-434

  Kassiotis, George ^a   Kollias, George ^b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

Autoimmunity; Cytokines; Encephalomyelitis multiple sclerosis; T lymphocytes; Transgenic knockout

Indexed keywords

CYTOKINE; MYELIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNE DISEASE; DEMYELINATING DISEASE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MEMORY CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGIC MEMORY; MICE; MICE, MUTANT STRAINS; MYELIN BASIC PROTEINS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035910751     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.4.427     Document Type: Article

References (31)

1. MS: A CNS and systemic autoimmune disease
2. Assessment of animal models for MS and demyelinating disease in the design of rational therapy
3. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo
4. Regulation of autoimmunity by proinflammatory cytokines
5. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis
6. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
7. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis
8. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting
9. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis
10. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/ p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy
11. A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice
12. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
13. TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
14. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
15. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1
16. Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
17. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
18. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
19. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice
20. Alternative pathways for the selection of antigen-specific peripheral T cells
21. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers
22. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
23. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment
24. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts
25. Immununological tolerance to a pancreatic antigen as a result of local expression of TNFalpha by islet beta cells
26. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis
27. Tumour necrosis factor-alpha in murine autoimmune "lupus" nephritis
28. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor
29. Role of cytokines in rheumatoid arthritis
30. Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
31. TNF-deficient mice develop anti-nuclear autoantibodies